Bayer flags strong results of prostate cancer drug

Jun 06, 2011

German chemical and pharmaceutical group Bayer said Monday that its Alpharadin treatment for prostate cancer has shown positive results in advanced trials.

Bayer developed Alpharadin with the Norwegian lab Algeta and tested it on 922 people in Phase III trials, a statement said.

Those on the treatment lived an average 14 months after the course began, compared with an average of 11.2 months for those given a placebo, it added.

The tests were abandoned early to allow the latter to be given Alpharadin as well.

It has not yet been approved for general sale but Bayer has placed strong hopes in the compound, radium-223 chloride, which attacks in bones.

"Around 90 percent of men with advanced prostate cancer have which are the main cause of disability and death in this disease," the statement said.

Prostate cancer is the most frequent form of cancer among men in Northern Europe and the United States. In 2008, an estimated 903,000 men had worldwide and 250,000 died from the disease, Bayer said.

The news was welcomed on Frankfurt's stock exchange, where Bayer shares gained 1.98 percent to 56.53 euros to lead gainers on the DAX index which was 0.27 percent lower overall.

Explore further: Spicy treatment the answer to aggressive cancer?

Related Stories

Sunshine pill for prostate cancer in 2009

Jan 16, 2007

A tablet designed to emulate the healing power of the sun could be available for the treatment of advanced prostate cancer as early as 2009. But it remains to be seen whether the drug will be the revolution in prostate cancer ...

New treatment hope for prostate cancer

Feb 06, 2009

Scientists at Melbourne's Burnet Institute have developed a potential new treatment for patients with prostate cancer. An article, which described the invention, has recently been published in the prestigious international ...

Recommended for you

Spicy treatment the answer to aggressive cancer?

2 hours ago

It has been treasured by food lovers for thousands of years for its rich golden colour, peppery flavour and mustardy aroma…and now turmeric may also have a role in fighting cancer.

Cancer survivors who smoke perceive less risk from tobacco

19 hours ago

Cancer survivors who smoke report fewer negative opinions about smoking, have more barriers to quitting, and are around other smokers more often than survivors who had quit before or after their diagnosis, according to a ...

Melanoma mutation rewires cell metabolism

19 hours ago

A mutation found in most melanomas rewires cancer cells' metabolism, making them dependent on a ketogenesis enzyme, researchers at Winship Cancer Institute of Emory University have discovered.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.